Lifecore Biomedical, Inc. Common Stock

LFCRNASDAQ • USD
6.42 USD
↗ 0.00 (0.00%)🟢LIVE (AS OF 12:05 PM EST)
🟢Market: OPEN

Shares of Lifecore Biomedical, Inc. Common Stock (LFCR) are trading at $6.42. LFCR shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (336.7%), a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$6.41
High?$6.42
Low?$6.40
Prev. Close?$6.42
Volume?27.0K
Avg. Volume?481.4K
VWAP?$6.41
Rel. Volume?0.06x
Bid / Ask
Bid?$6.41 × 500
Ask?$6.42 × 500
Spread?$0.01
Midpoint?$6.42
Valuation & Ratios
Market Cap?243.4M
Shares Out?37.9M
Float?24.2M
Float %?64.0%
P/E Ratio?N/A
P/B Ratio?-10.92
EPS?-$1.98
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Employees
382
Market Cap
243.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1996-02-15
Address
3515 LYMAN BOULEVARD
CHASKA, MN 55318
Phone: (952) 368-4300
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
1
Momentum?
50
Short Sent.?
60
Piotroski F-Score?4/9Mixed
Altman Z-Score?-0.42Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.10%Elevated
Short Interest?1.7M
Days to Cover?3.5
Free Float24.2M
Avg Daily Volume489.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.84Strong
Quick Ratio?2.59Strong
Cash Ratio?1.05Strong
Debt/Equity?-0.25Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-10.92CHEAP▾
P/S?
Peers
100
S&P
63
2.14CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-60.1CHEAP▾
EV/Sales?
Peers
100
S&P
75
1.98CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
336.7%STRONG▾
ROA?
S&P
3
-32.9%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$225.9M
Fundamentals ratios updated end of day